RespireRx Pharmaceuticals Inc. — Regulation A 1-A/A
RespireRx Pharmaceuticals Inc. of Glen Rock, NJ filed a Regulation A 1-A/A with the SEC on 2021-10-12. Aggregate offering: $7.5M (Tier 2). Industry: Other.
Offering
- Filed: 2021-10-12
- Form: 1-A/A
- Accession: 0001493152-21-025228
- Tier: Tier 2
- Total aggregate offering: $7.5M
- Issuer portion: $7.5M
- Price per security: $0.0250
- Securities offered: Equity (common or preferred stock)
- Underwriter: None
- Broker-dealer CRD: 127921
- Audit status: Audited
- Auditor: Haskell & White LLP
- Jurisdictions: 32 states/territories
Issuer
- CIK: 0000849636
- Organized in: DE
- Incorporated: 1987
- Address: 126 Valley Road, Suite C, Glen Rock, NJ, 07452
- Phone: 201-444-4947
- Employees: 12 full-time
Financial snapshot (as filed)
- Total assets: $85K
- Cash & equivalents: $825
- Total liabilities: $8.1M
- Stockholder equity: $-8.1M
- Net income: $-5.7M
People (1)
| Name | Role | Location |
|---|
| Jeff Eliot Margolis | Signer | Glen Rock, NJ |
Other Reg A filings by this issuer (2)
More